ARTICLE | Company News
Lilly Icos submits Cialis NDA
June 28, 2001 7:00 AM UTC
Lilly Icos, the joint venture between Icos (ICOS) and Eli Lilly (LLY), submitted an NDA for its Cialis phosphodiesterase-5 (PDE-5) inhibitor to treat erectile dysfunction. ICOS was up $4.05 to $64 on ...